Hany Massarany - Jan 31, 2022 Form 4 Insider Report for Accelerate Diagnostics, Inc (AXDX)

Role
Director
Signature
/s/ Steven Reichling, attorney-in-fact
Stock symbol
AXDX
Transactions as of
Jan 31, 2022
Transactions value $
$66,000
Form type
4
Date filed
2/1/2022, 05:05 PM
Previous filing
Sep 28, 2021
Next filing
May 26, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AXDX Common Stock Purchase $66K +20K +200% $3.30 30K Jan 31, 2022 Massarany Family Trust dated November 15, 2012 F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.18 to $3.35, inclusive. The reporting person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4.
F2 Mr. Massarany is a trustee of the Massarany Family Trust and may be deemed to have beneficial ownership of these securities, to the extent of any indirect pecuniary interest in his distributive shares therein.